🇺🇸 FDA
Patent

US 8933236

N-substituted benzamides and methods of use thereof

granted A61KA61K31/18A61K31/397

Quick answer

US patent 8933236 (N-substituted benzamides and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/18, A61K31/397, A61K31/40, A61K31/41